Bluejay Diagnostics (BJDX) Long-Term Deferred Tax (2021 - 2022)
Bluejay Diagnostics' Long-Term Deferred Tax history spans 2 years, with the latest figure at $2.7 million for Q4 2022.
- On a quarterly basis, Long-Term Deferred Tax rose 200.0% to $2.7 million in Q4 2022 year-over-year; TTM through Dec 2022 was $2.7 million, a 200.0% increase, with the full-year FY2022 number at $2.7 million, up 200.0% from a year prior.
- Long-Term Deferred Tax hit $2.7 million in Q4 2022 for Bluejay Diagnostics, up from $900000.0 in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for BJDX hit a ceiling of $2.7 million in Q4 2022 and a floor of $900000.0 in Q4 2021.